Saudi Pharmaceutical Industries and Medical Appliances Corp. ( SPIMACO ) reported a net loss after zakat and tax of SAR 207.79 million for the first half of 2019, as compared to a net profit of SAR 53.18 million a year earlier.
The loss was driven by a decrease in gross profit ue to the difference in the mix of products sold as well as decline in product prices.
| Item | 6m 2018 | 6m 2019 | Change |
|---|---|---|---|
| Revenues | 677.58 | 799.83 | 18.0 % |
| Gross Income | 342.84 | 247.53 | (27.8 %) |
| Operating Income | 65.80 | (48.05) | (173.0 %) |
| Net Income | 69.69 | (208.20) | (398.8 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.58 | (1.74) | (398.8 %) |
In Q2 2019, the company posted a net loss after zakat and tax of SAR 188.54 million versus a net profit of SAR 12.26 million due to an adjustment of the provision for sales recovery according to requirements of IFRS.
On a sequential basis, Q2 net loss widened from the previous quarter’s loss of SAR 13.15 million on lower product prices.
| Item | Q2 2018 | Q2 2019 | Change |
|---|---|---|---|
| Revenues | 295.62 | 355.03 | 20.1 % |
| Gross Income | 155.28 | 95.10 | (38.8 %) |
| Operating Income | 10.00 | (65.02) | (750.4 %) |
| Net Income | 22.67 | (186.49) | (922.8 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | 0.19 | (1.55) | (922.8 %) |
| Item | Q1 2019 | Q2 2019 | Change |
|---|---|---|---|
| Revenues | 444.80 | 355.03 | (20.2 %) |
| Gross Income | 152.43 | 95.10 | (37.6 %) |
| Operating Income | 16.97 | (65.02) | (483.1 %) |
| Net Income | (21.71) | (186.49) | (759.2 %) |
| Average Shares | 120.00 | 120.00 | - |
| EPS (Riyals) | (0.18) | (1.55) | (759.2 %) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| Q1 2010 | 274.33 | 6.4 % | 118.90 | 9.5 % | 45.32 | 6.2 % | 0.38 |
| Q2 2010 | 252.34 | 10.2 % | 100.50 | 23.3 % | 43.09 | 14.0 % | 0.36 |
| Q3 2010 | 191.40 | 11.8 % | 85.88 | 18.5 % | 18.07 | 14.1 % | 0.15 |
| Q4 2010 | 319.57 | 9.2 % | 181.12 | 15.4 % | 70.04 | 19.8 % | 0.58 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| Q1 2011 | 252.08 | (8.1 %) | 123.51 | 3.9 % | 45.71 | 0.9 % | 0.38 |
| Q2 2011 | 292.08 | 15.7 % | 123.61 | 23.0 % | 60.75 | 41.0 % | 0.51 |
| Q3 2011 | 209.24 | 9.3 % | 106.76 | 24.3 % | 29.75 | 64.6 % | 0.25 |
| Q4 2011 | 375.82 | 17.6 % | 206.69 | 14.1 % | 74.06 | 5.7 % | 0.62 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| Q1 2012 | 303.14 | 20.3 % | 153.21 | 24.0 % | 56.45 | 23.5 % | 0.47 |
| Q2 2012 | 286.64 | (1.9 %) | 140.91 | 14.0 % | 90.14 | 48.4 % | 0.75 |
| Q3 2012 | 227.40 | 8.7 % | 113.28 | 6.1 % | 32.33 | 8.7 % | 0.27 |
| Q4 2012 | 365.97 | (2.6 %) | 211.16 | 2.2 % | 53.73 | (27.5 %) | 0.45 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| Q1 2013 | 361.37 | 19.2 % | 184.62 | 20.5 % | 63.15 | 11.9 % | 0.53 |
| Q2 2013 | 344.22 | 20.1 % | 179.12 | 27.1 % | 113.71 | 26.1 % | 0.95 |
| Q3 2013 | 222.91 | (2.0 %) | 118.64 | 4.7 % | 34.19 | 5.8 % | 0.28 |
| Q4 2013 | 382.01 | 4.4 % | 226.14 | 7.1 % | 57.01 | 6.1 % | 0.48 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| Q1 2014 | 405.21 | 12.1 % | 206.72 | 12.0 % | 91.17 | 44.4 % | 0.76 |
| Q2 2014 | 371.14 | 7.8 % | 193.14 | 7.8 % | 97.72 | (14.1 %) | 0.81 |
| Q3 2014 | 266.02 | 19.3 % | 134.45 | 13.3 % | 36.69 | 7.3 % | 0.31 |
| Q4 2014 | 431.06 | 12.8 % | 261.80 | 15.8 % | 91.29 | 60.1 % | 0.76 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| Q1 2015 | 432.20 | 6.7 % | 225.86 | 9.3 % | 99.39 | 9.0 % | 0.83 |
| Q2 2015 | 435.80 | 17.4 % | 210.95 | 9.2 % | 237.63 | 143.2 % | 1.98 |
| Q3 2015 | 308.27 | 15.9 % | 131.32 | (2.3 %) | 29.16 | (20.5 %) | 0.24 |
| Q4 2015 | 520.38 | 20.7 % | 266.38 | 1.7 % | (9.12) | (110.0 %) | (0.08) |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| Q1 2016 | 322.20 | (25.4 %) | 194.26 | (14.0 %) | 88.91 | (10.5 %) | 0.74 |
| Q2 2016 | 339.54 | (22.1 %) | 183.58 | (13.0 %) | 39.61 | (83.3 %) | 0.33 |
| Q3 2016 | 257.21 | (16.6 %) | 140.54 | 7.0 % | 4.76 | (83.7 %) | 0.04 |
| Q4 2016 | 339.59 | (34.7 %) | 194.16 | (27.1 %) | 143.48 | 1673.8 % | 1.20 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| Q1 2017 | 393.10 | 22.0 % | 212.58 | 9.4 % | 101.22 | 13.8 % | 0.84 |
| Q2 2017 | 304.63 | (10.3 %) | 156.13 | (15.0 %) | 46.56 | 17.5 % | 0.39 |
| Q3 2017 | 277.62 | 7.9 % | 128.68 | (8.4 %) | (17.03) | (457.9 %) | (0.14) |
| Q4 2017 | 410.69 | 20.9 % | 207.07 | 6.7 % | 66.61 | (53.6 %) | 0.56 |
| 2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
| Q1 2018 | 390.79 | (0.6 %) | 197.32 | (7.2 %) | 55.23 | (45.4 %) | 0.46 |
| Q2 2018 | 295.62 | (3.0 %) | 155.28 | (0.5 %) | 22.67 | (51.3 %) | 0.19 |
| Q3 2018 | 224.95 | (19.0 %) | 137.89 | 7.2 % | (12.12) | 28.8 % | (0.10) |
| Q4 2018 | 600.79 | 46.3 % | 127.79 | (38.3 %) | 19.01 | (71.5 %) | 0.16 |
| 2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
| Q1 2019 | 444.80 | 13.8 % | 152.43 | (22.7 %) | (21.71) | (139.3 %) | (0.18) |
| Q2 2019 | 355.03 | 20.1 % | 95.10 | (38.8 %) | (186.49) | (922.8 %) | (1.55) |
| Period | Revenues | Change | Gross Income | Change | Net Income | Change | EPS(Riyal) |
|---|---|---|---|---|---|---|---|
| 2009 | 950.74 | 9.0 % | 419.59 | 15.6 % | 154.81 | 20.7 % | 1.53 |
| 2010 | 1,037.64 | 9.1 % | 486.40 | 15.9 % | 176.52 | 14.0 % | 1.47 |
| 2011 | 1,129.22 | 8.8 % | 560.57 | 15.2 % | 211.44 | 19.8 % | 1.76 |
| 2012 | 1,183.15 | 4.8 % | 618.56 | 10.3 % | 232.65 | 10.0 % | 1.94 |
| 2013 | 1,310.50 | 10.8 % | 708.52 | 14.5 % | 266.82 | 14.7 % | 2.22 |
| 2014 | 1,470.19 | 12.2 % | 794.54 | 12.1 % | 316.85 | 18.8 % | 2.64 |
| 2015 | 1,705.05 | 16.0 % | 848.60 | 6.8 % | 357.05 | 12.7 % | 2.98 |
| 2016 | 1,258.55 | (26.2 %) | 712.54 | (16.0 %) | 276.76 | (22.5 %) | 2.31 |
| 2017 | 1,386.04 | 10.1 % | 704.46 | (1.1 %) | 197.37 | (28.7 %) | 1.64 |
| 2018 | 1,503.32 | 8.5 % | 608.52 | (13.6 %) | 76.58 | (61.2 %) | 0.64 |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2010 | 44.45 % | 18.88 % | 16.94 % |
| Q2 2010 | 45.32 % | 18.93 % | 17.07 % |
| Q3 2010 | 45.73 % | 18.73 % | 16.95 % |
| Q4 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| Q1 2011 | 48.36 % | 18.99 % | 17.42 % |
| Q2 2011 | 48.73 % | 19.12 % | 18.44 % |
| Q3 2011 | 49.86 % | 19.99 % | 19.22 % |
| Q4 2011 | 49.64 % | 19.57 % | 18.62 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| Q1 2012 | 50.01 % | 19.86 % | 18.73 % |
| Q2 2012 | 51.72 % | 20.36 % | 21.31 % |
| Q3 2012 | 51.47 % | 20.54 % | 21.21 % |
| Q4 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| Q1 2013 | 52.36 % | 19.26 % | 19.28 % |
| Q2 2013 | 52.98 % | 18.87 % | 20.24 % |
| Q3 2013 | 53.58 % | 18.66 % | 20.45 % |
| Q4 2013 | 54.06 % | 18.26 % | 20.45 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| Q1 2014 | 53.95 % | 17.92 % | 21.86 % |
| Q2 2014 | 53.91 % | 17.74 % | 20.28 % |
| Q3 2014 | 53.39 % | 16.79 % | 19.84 % |
| Q4 2014 | 54.03 % | 18.15 % | 21.50 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| Q1 2015 | 54.34 % | 18.90 % | 21.67 % |
| Q2 2015 | 53.23 % | 18.31 % | 20.04 % |
| Q3 2015 | 51.63 % | 17.40 % | 19.05 % |
| Q4 2015 | 49.19 % | 17.17 % | 19.11 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| Q1 2016 | 50.60 % | 15.90 % | 18.80 % |
| Q2 2016 | 52.04 % | 15.52 % | 16.88 % |
| Q3 2016 | 54.52 % | 15.09 % | 15.79 % |
| Q4 2016 | 56.62 % | 10.25 % | 5.68 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| Q1 2017 | 54.97 % | 9.67 % | 3.99 % |
| Q2 2017 | 54.34 % | 11.85 % | 4.64 % |
| Q3 2017 | 52.59 % | 11.94 % | 2.91 % |
| Q4 2017 | 50.83 % | 14.96 % | 9.94 % |
| 2017 | 50.83 % | 14.96 % | 9.94 % |
| Q1 2018 | 49.81 % | 16.45 % | 9.97 % |
| Q2 2018 | 50.07 % | 14.49 % | 8.30 % |
| Q3 2018 | 52.76 % | 15.07 % | 9.00 % |
| Q4 2018 | 40.89 % | 5.68 % | 5.61 % |
| 2018 | 40.48 % | 4.92 % | 5.09 % |
| Q1 2019 | 36.61 % | 2.64 % | 0.50 % |
| Q2 2019 | 31.57 % | (2.89 %) | (5.68 %) |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| 2009 | 44.13 % | 18.49 % | 16.63 % |
| 2010 | 46.88 % | 18.85 % | 17.32 % |
| 2011 | 49.64 % | 19.65 % | 18.72 % |
| 2012 | 52.28 % | 19.56 % | 19.66 % |
| 2013 | 54.06 % | 18.16 % | 20.36 % |
| 2014 | 54.04 % | 18.15 % | 21.55 % |
| 2015 | 49.77 % | 16.85 % | 19.02 % |
| 2016 | 56.62 % | 10.25 % | 5.68 % |
| 2017 | 50.83 % | 14.96 % | 9.94 % |
| 2018 | 40.48 % | 4.92 % | 5.09 % |
| Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
|---|---|---|---|
| Q1 2010 | 43.34 % | 21.92 % | 17.70 % |
| Q2 2010 | 39.83 % | 11.52 % | 17.08 % |
| Q3 2010 | 44.87 % | 14.68 % | 9.44 % |
| Q4 2010 | 56.68 % | 24.50 % | 21.92 % |
| Q1 2011 | 49.00 % | 22.74 % | 18.13 % |
| Q2 2011 | 42.32 % | 13.00 % | 20.80 % |
| Q3 2011 | 51.02 % | 19.57 % | 14.22 % |
| Q4 2011 | 55.00 % | 22.56 % | 19.71 % |
| Q1 2012 | 50.54 % | 23.32 % | 18.62 % |
| Q2 2012 | 49.16 % | 14.95 % | 31.45 % |
| Q3 2012 | 49.82 % | 20.53 % | 14.22 % |
| Q4 2012 | 57.70 % | 19.47 % | 14.68 % |
| Q1 2013 | 51.09 % | 21.68 % | 17.48 % |
| Q2 2013 | 52.04 % | 14.20 % | 33.03 % |
| Q3 2013 | 53.22 % | 19.34 % | 15.34 % |
| Q4 2013 | 59.20 % | 18.05 % | 14.92 % |
| Q1 2014 | 51.02 % | 20.19 % | 22.50 % |
| Q2 2014 | 52.04 % | 13.80 % | 26.33 % |
| Q3 2014 | 50.54 % | 13.97 % | 13.79 % |
| Q4 2014 | 60.73 % | 22.54 % | 21.18 % |
| Q1 2015 | 52.26 % | 22.70 % | 23.00 % |
| Q2 2015 | 48.40 % | 12.42 % | 19.81 % |
| Q3 2015 | 42.60 % | 9.85 % | 9.46 % |
| Q4 2015 | 51.19 % | 20.88 % | 21.02 % |
| Q1 2016 | 60.29 % | 18.36 % | 22.80 % |
| Q2 2016 | 54.07 % | 9.77 % | 11.67 % |
| Q3 2016 | 54.64 % | 6.30 % | 1.85 % |
| Q4 2016 | 57.18 % | 6.04 % | (13.65 %) |
| Q1 2017 | 54.08 % | 14.94 % | 14.01 % |
| Q2 2017 | 51.25 % | 19.02 % | 15.29 % |
| Q3 2017 | 46.35 % | 7.17 % | (6.13 %) |
| Q4 2017 | 50.42 % | 17.25 % | 12.96 % |
| Q1 2018 | 50.49 % | 20.19 % | 14.13 % |
| Q2 2018 | 52.53 % | 9.98 % | 7.67 % |
| Q3 2018 | 61.30 % | 8.88 % | (5.39 %) |
| Q4 2018 | 21.27 % | (7.08 %) | 3.16 % |
| Q1 2019 | 34.27 % | 7.75 % | (4.88 %) |
| Q2 2019 | 26.79 % | (16.60 %) | (21.86 %) |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| Q1 2010 | 120.00 | 1.31 | 1.36 | 22.04 |
| Q2 2010 | 120.00 | 1.36 | 1.41 | 19.98 |
| Q3 2010 | 120.00 | 1.37 | 1.43 | 21.69 |
| Q4 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| Q1 2011 | 120.00 | 1.47 | 1.47 | 25.41 |
| Q2 2011 | 120.00 | 1.62 | 1.62 | 27.29 |
| Q3 2011 | 120.00 | 1.72 | 1.72 | 25.92 |
| Q4 2011 | 120.00 | 1.75 | 1.75 | 26.50 |
| Q1 2012 | 120.00 | 1.84 | 1.84 | 30.26 |
| Q2 2012 | 120.00 | 2.09 | 2.09 | 25.75 |
| Q3 2012 | 120.00 | 2.11 | 2.11 | 26.24 |
| Q4 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| Q1 2013 | 120.00 | 1.99 | 1.99 | 27.18 |
| Q2 2013 | 120.00 | 2.19 | 2.19 | 26.14 |
| Q3 2013 | 120.00 | 2.21 | 2.21 | 27.35 |
| Q4 2013 | 120.00 | 2.23 | 2.23 | 32.18 |
| Q1 2014 | 120.00 | 2.47 | 2.47 | 32.96 |
| Q2 2014 | 120.00 | 2.33 | 2.33 | 33.21 |
| Q3 2014 | 120.00 | 2.35 | 2.35 | 35.74 |
| Q4 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| Q1 2015 | 120.00 | 2.71 | 2.71 | 27.84 |
| Q2 2015 | 120.00 | 3.87 | 2.61 | 28.72 |
| Q3 2015 | 120.00 | 3.81 | 2.55 | 24.87 |
| Q4 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| Q1 2016 | 120.00 | 2.89 | 2.49 | 20.84 |
| Q2 2016 | 120.00 | 1.24 | 2.10 | 20.49 |
| Q3 2016 | 120.00 | 1.03 | 1.89 | 20.40 |
| Q4 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| Q1 2017 | 120.00 | 2.41 | 0.44 | 23.27 |
| Q2 2017 | 120.00 | 2.47 | 0.50 | 21.52 |
| Q3 2017 | 120.00 | 2.29 | 0.32 | 22.01 |
| Q4 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
| Q1 2018 | 120.00 | 1.26 | 1.15 | 25.04 |
| Q2 2018 | 120.00 | 1.06 | 0.95 | 25.74 |
| Q3 2018 | 120.00 | 1.10 | 0.99 | 24.32 |
| Q4 2018 | 120.00 | 0.71 | 0.71 | 21.17 |
| Q1 2019 | 120.00 | 0.07 | 0.07 | 22.80 |
| Q2 2019 | 120.00 | (1.68) | (0.77) | 19.63 |
| Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
|---|---|---|---|---|
| 2009 | 101.51 | 1.53 | 1.56 | 21.46 |
| 2010 | 120.00 | 1.47 | 1.50 | 24.48 |
| 2011 | 120.00 | 1.76 | 1.76 | 26.50 |
| 2012 | 120.00 | 1.94 | 1.94 | 25.28 |
| 2013 | 120.00 | 2.22 | 2.22 | 32.18 |
| 2014 | 120.00 | 2.64 | 2.64 | 28.75 |
| 2015 | 120.00 | 2.98 | 2.70 | 22.17 |
| 2016 | 120.00 | 2.31 | 0.60 | 22.59 |
| 2017 | 120.00 | 1.64 | 1.15 | 22.78 |
| 2018 | 120.00 | 0.64 | 0.64 | 21.17 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| Q1 2010 | 16.69 | 16.04 | 0.99 |
| Q2 2010 | 14.70 | 14.15 | 1.00 |
| Q3 2010 | 14.64 | 14.10 | 0.93 |
| Q4 2010 | 15.82 | 15.53 | 0.95 |
| Q1 2011 | 17.65 | 17.65 | 1.02 |
| Q2 2011 | 15.68 | 15.68 | 0.93 |
| Q3 2011 | 14.41 | 14.41 | 0.96 |
| Q4 2011 | 15.03 | 15.03 | 0.99 |
| Q1 2012 | 17.92 | 17.92 | 1.09 |
| Q2 2012 | 12.56 | 12.56 | 1.02 |
| Q3 2012 | 13.70 | 13.70 | 1.10 |
| Q4 2012 | 14.74 | 14.74 | 1.13 |
| Q1 2013 | 13.60 | 13.60 | 1.00 |
| Q2 2013 | 15.51 | 15.51 | 1.30 |
| Q3 2013 | 15.70 | 15.70 | 1.27 |
| Q4 2013 | 19.02 | 19.02 | 1.32 |
| Q1 2014 | 19.07 | 19.07 | 1.43 |
| Q2 2014 | 19.29 | 19.29 | 1.36 |
| Q3 2014 | 21.41 | 21.41 | 1.41 |
| Q4 2014 | 12.89 | 12.89 | 1.18 |
| Q1 2015 | 14.78 | 14.78 | 1.44 |
| Q2 2015 | 11.59 | 17.18 | 1.56 |
| Q3 2015 | 9.46 | 14.14 | 1.45 |
| Q4 2015 | 11.16 | 12.29 | 1.50 |
| Q1 2016 | 11.15 | 12.96 | 1.55 |
| Q2 2016 | 29.96 | 17.69 | 1.81 |
| Q3 2016 | 30.18 | 16.49 | 1.53 |
| Q4 2016 | 17.72 | 68.63 | 1.81 |
| Q1 2017 | 15.03 | 81.82 | 1.56 |
| Q2 2017 | 14.32 | 70.59 | 1.64 |
| Q3 2017 | 14.43 | More than 100 | 1.50 |
| Q4 2017 | 18.25 | 26.14 | 1.32 |
| Q1 2018 | 24.34 | 26.70 | 1.23 |
| Q2 2018 | 30.03 | 33.56 | 1.24 |
| Q3 2018 | 28.37 | 31.57 | 1.29 |
| Q4 2018 | 41.61 | 41.61 | 1.39 |
| Q1 2019 | More than 100 | More than 100 | 1.21 |
| Q2 2019 | NEG | NEG | 1.35 |
| Period | P/E | Adjusted P/E | Price/book |
|---|---|---|---|
| 2009 | 15.25 | 14.94 | 1.08 |
| 2010 | 15.82 | 15.53 | 0.95 |
| 2011 | 14.95 | 14.95 | 0.99 |
| 2012 | 14.74 | 14.74 | 1.13 |
| 2013 | 19.11 | 19.11 | 1.32 |
| 2014 | 12.89 | 12.89 | 1.18 |
| 2015 | 11.16 | 12.29 | 1.50 |
| 2016 | 17.72 | 68.63 | 1.81 |
| 2017 | 18.25 | 26.14 | 1.32 |
| 2018 | 46.07 | 46.07 | 1.39 |
Q2 2019
2019
| Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|---|---|---|---|
| Q1 2010 | - | - | - | - | 274.33 | - | - |
| Q2 2010 | - | - | - | - | 252.34 | - | - |
| Q3 2010 | - | - | - | - | 191.41 | - | - |
| Q4 2010 | - | - | - | - | 319.57 | - | - |
| Q1 2011 | - | - | - | - | 252.08 | - | - |
| Q2 2011 | - | - | - | - | 292.08 | - | - |
| Q3 2011 | - | - | - | - | 209.24 | - | - |
| Q4 2011 | - | - | - | - | 375.82 | - | - |
| Q1 2012 | - | - | - | - | 303.14 | - | - |
| Q2 2012 | - | - | - | - | 286.65 | - | - |
| Q3 2012 | - | - | - | - | 227.40 | - | - |
| Q4 2012 | - | - | - | - | 365.97 | - | - |
| Q1 2013 | - | - | - | - | 361.37 | - | - |
| Q2 2013 | - | - | - | - | 344.22 | - | - |
| Q3 2013 | - | - | - | - | 222.91 | - | - |
| Q4 2013 | - | - | - | - | 382.01 | - | - |
| Q1 2014 | - | - | - | - | 405.21 | - | - |
| Q2 2014 | - | - | - | - | 374.14 | - | - |
| Q3 2014 | - | - | - | - | 266.02 | - | - |
| Q4 2014 | - | - | - | - | 427.82 | - | - |
| Q1 2015 | - | - | - | - | 432.29 | 14.84 | - |
| Q2 2015 | - | - | - | - | 436.99 | 195.93 | - |
| Q3 2015 | - | - | - | - | 308.38 | 9.55 | - |
| Q4 2015 | - | - | - | - | 529.24 | - | - |
| Q1 2016 | - | - | - | - | 513.97 | 25.27 | - |
| Q2 2016 | - | - | - | - | 494.92 | 9.41 | - |
| Q3 2016 | - | - | - | - | 100.39 | 6.23 | - |
| Q4 2016 | - | - | - | - | 401.35 | 247.84 | - |
| Q1 2017 | - | - | - | - | 446.00 | 50.90 | (51.45) |
| Q2 2017 | - | - | - | - | 350.01 | 1.39 | (43.30) |
| Q3 2017 | - | - | - | - | 317.29 | 4.01 | (36.78) |
| Q4 2017 | - | - | - | - | 486.15 | - | (54.74) |
| Q1 2018 | - | - | - | - | 450.19 | 7.00 | (57.49) |
| Q3 2018 | 172.41 | 34.26 | 1.75 | 16.54 | - | - | - |
| Q1 2019 | 419.76 | 22.19 | 2.03 | 0.82 | - | - | - |
| Q2 2019 | 334.00 | 19.00 | 0.91 | 1.12 | - | - | - |
| Period | Pharmaceutical Manufacturing | healthy services and other | Trading & Distribution Services | Contract manufacturing arrangements | Medical & Pharmaceutical production segment | Investment activity | Eliminations |
|---|---|---|---|---|---|---|---|
| 2009 | - | - | - | - | 950.74 | - | - |
| 2010 | - | - | - | - | 1,037.64 | - | - |
| 2011 | - | - | - | - | 1,129.22 | - | - |
| 2012 | - | - | - | - | 1,183.15 | - | - |
| 2013 | - | - | - | - | 1,310.50 | - | - |
| 2014 | - | - | - | - | 1,470.19 | - | - |
| 2015 | - | - | - | - | 1,706.80 | 115.14 | - |
| 2016 | - | - | - | - | 1,510.63 | 288.74 | (244.41) |
| 2017 | - | - | - | - | 1,599.45 | 61.92 | (186.28) |
| 2018 | 1,414.72 | 78.37 | 5.02 | 5.22 | - | - | - |
| Current | |
| Market Cap (M Riyal) | 3,528.00 |
| Enterprise Value (EV) (M) | 4,609.48 |
| Shares Outstanding ((M)) | 120.00 |
| EPS ( Riyal) (TTM) | (0.27) |
| Book Value (BV) ( Riyal) | 12.89 |
| Par Value ( Riyal) | 10.00 |
| Adjusted P/E (Last12) | Neg |
| P/E (TTM) | NEG |
| Price/book | 2.28 |
| Return on Average Assets (%) (TTM) | (0.76 ) |
| Return on Average Equity (%) (TTM) | (2.09 ) |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}